Fifty Years with Aspirin and Platelets

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2022 Oct 3

PMID 36189951

Authors

Carlo Patrono

Affiliations

Soon will be listed here.

Abstract

In 2021, we reached the 50th anniversary of the publication of Sir John Vane's seminal paper in Nature New Biology describing the experiments supporting his mechanistic hypothesis that inhibition of prostaglandin synthesis might explain the main pharmacological effects of aspirin and aspirin-like drugs, that is, reduction in pain, fever and inflammation. Bengt Samuelsson's subsequent discoveries elucidating the cyclooxygenase pathway of platelet arachidonic acid metabolism motivated my research interest towards measuring platelet thromboxane A biosynthesis as a tool to investigate the clinical pharmacology of cyclooxygenase inhibition by aspirin in health and disease. What followed was a long, winding road of clinical research leading to the characterization of low-dose aspirin as a life-saving antiplatelet drug that still represents the cornerstone of antithrombotic therapy. Having witnessed and participated in these 50 years of aspirin research, I thought of providing a personal testimony of how things developed and eventually led to a remarkable success story of independent research.

Citing Articles

Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances.

Laila U, Zhao Z, Liu H, Xu Z Int J Nanomedicine. 2025; 20:2327-2365.

PMID: 40017626 PMC: 11866938. DOI: 10.2147/IJN.S505636.

New Insights into Aspirin's Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites.

Kontoghiorghes G Antioxidants (Basel). 2025; 14(1).

PMID: 39857363 PMC: 11763074. DOI: 10.3390/antiox14010029.

Association of early aspirin use with 90-day mortality in patients with sepsis: an PSM analysis of the MIMIC-IV database.

Huang C, Tong Q, Zhang W, Pan Z Front Pharmacol. 2025; 15():1475414.

PMID: 39850571 PMC: 11754289. DOI: 10.3389/fphar.2024.1475414.

Balancing bleeding, thrombosis and myocardial injury: A call for balance and precision medicine for aspirin in neurosurgery.

Niyogi S, Batta A, Mohan B World J Cardiol. 2024; 16(12):673-676.

PMID: 39734823 PMC: 11669977. DOI: 10.4330/wjc.v16.i12.673.

Guideline concordance of aspirin use for primary prevention in adult outpatients.

Chipalkatti N, Barnes G, Bashaw L, Davie A, Griggs J, Harrod M Blood Adv. 2024; 8(24):6207-6214.

PMID: 39374577 PMC: 11697097. DOI: 10.1182/bloodadvances.2024014220.

References

. The aspirin dilemma revisited. N Engl J Med. 1984; 310(20):1326-7. DOI: 10.1056/NEJM198405173102014. View

Born G . Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962; 194:927-9. DOI: 10.1038/194927b0. View

Patrono C, Pugliese F, Ciabattoni G, Patrignani P, Maseri A, Chierchia S . Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest. 1982; 69(1):231-9. PMC: 371187. DOI: 10.1172/jci110435. View

Hamberg M, Svensson J, Wakabayashi T, Samuelsson B . Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974; 71(2):345-9. PMC: 388001. DOI: 10.1073/pnas.71.2.345. View

Li X, Fries S, Li R, Lawson J, Propert K, Diamond S . Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 2014; 111(47):16830-5. PMC: 4250103. DOI: 10.1073/pnas.1406997111. View

Taylor D, Barnett H, Haynes R, Ferguson G, Sackett D, Thorpe K . Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999; 353(9171):2179-84. DOI: 10.1016/s0140-6736(99)05388-x. View

Cariello M, Piccinin E, Pasculli E, Arconzo M, Zerlotin R, DAmore S . Platelets from patients with visceral obesity promote colon cancer growth. Commun Biol. 2022; 5(1):553. PMC: 9174292. DOI: 10.1038/s42003-022-03486-7. View

Hamberg M, Samuelsson B . Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974; 71(9):3400-4. PMC: 433780. DOI: 10.1073/pnas.71.9.3400. View

Cook N, Lee I, Zhang S, Moorthy M, Buring J . Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013; 159(2):77-85. PMC: 3713531. DOI: 10.7326/0003-4819-159-2-201307160-00002. View

10.

Patrono C . Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. Br J Clin Pharmacol. 2016; 82(4):957-64. PMC: 5137820. DOI: 10.1111/bcp.13048. View

11.

Piper P, Vane J . Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969; 223(5201):29-35. DOI: 10.1038/223029a0. View

12.

Joharatnam-Hogan N, Cafferty F, Hubner R, Swinson D, Sothi S, Gupta K . Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. Lancet Gastroenterol Hepatol. 2019; 4(11):854-862. DOI: 10.1016/S2468-1253(19)30289-4. View

13.

Grosser T, Fries S, Lawson J, Kapoor S, Grant G, FitzGerald G . Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation. 2012; 127(3):377-85. PMC: 3552520. DOI: 10.1161/CIRCULATIONAHA.112.117283. View

14.

Pinckard R, Hawkins D, Farr R . In vitro acetylation of plasma proteins, enzymes and DNA by aspirin. Nature. 1968; 219(5149):68-9. DOI: 10.1038/219068a0. View

15.

Vane J . The release and fate of vaso-active hormones in the circulation. Br J Pharmacol. 1969; 35(2):209-42. PMC: 1703229. DOI: 10.1111/j.1476-5381.1969.tb07982.x. View

16.

Patrono C . The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin. J Am Coll Cardiol. 2015; 66(1):74-85. DOI: 10.1016/j.jacc.2015.05.012. View

17.

Evans G, Packham M, NISHIZAWA E, Mustard J, Murphy E . The effect of acetylsalicyclic acid on platelet function. J Exp Med. 1968; 128(5):877-94. PMC: 2138560. DOI: 10.1084/jem.128.5.877. View

18.

GAST L . INFLUENCE OF ASPIRIN ON HAEMOSTATIC PARAMETERS. Ann Rheum Dis. 1964; 23:500-4. PMC: 1030967. DOI: 10.1136/ard.23.6.500. View

19.

Burn J, Bishop D, Mecklin J, Macrae F, Moslein G, Olschwang S . Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008; 359(24):2567-78. DOI: 10.1056/NEJMoa0801297. View

20.

Rocca B, Santilli F, Pitocco D, Mucci L, Petrucci G, Vitacolonna E . The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Haemost. 2012; 10(7):1220-30. DOI: 10.1111/j.1538-7836.2012.04723.x. View